CoChat
Sign Up
Cited by 101TGF-β signaling in diseasesMesenchymal stem cell researchBone Metabolism and Diseases

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.

PDGF-AA Promotes Osteogenic Differentiation and Migration of Mesenchymal Stem Cell by Down-Regulating PDGFRα and Derepressing BMP-Smad1/5/8 Signaling

Open access
Li, Anna, Xia, Xuechun, Yeh, James, Kua, Huiyi, Liu, Huijuan, Mishina, Yuji, Hao, Aijun, Li, Baojie·2014·PLoS ONE
DOI 10.1371/journal.pone.0113785PMC PMC4254917
Open this paper in CoChat — free accountOpen PDF

Abstract

Platelet-derived growth factors (PDGFs) play important roles in skeletal development and bone fracture healing, yet how PDGFs execute their functions remains incompletely understood. Here we show that PDGF-AA, but not -AB or -BB, could activate the BMP-Smad1/5/8 pathway in mesenchymal stem cells (MSCs), which requires BMPRIA as well as PDGFRα. PDGF-AA promotes MSC osteogenic differentiation through the BMP-Smad1/5/8-Runx2/Osx axis and MSC migration via the BMP-Smad1/5/8-Twist1/Atf4 axis. Mechanistic studies show that PDGF-AA activates BMP-Smad1/5/8 signaling by feedback down-regulating PDGFRα, which frees BMPRI and allows for BMPRI-BMPRII complex formation to activate smad1/5/8, using BMP molecules in the microenvironment. This study unravels a physical and functional interaction between PDGFRα and BMPRI, which plays an important role in MSC differentiation and migration, and establishes a link between PDGF-AA and BMPs pathways, two essential regulators of embryonic development and tissue homeostasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0113785

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 PDGF-AA activates BMP-Smad1/5/8 pathway via BMPRIA in MSC cells. A. PDGF-AA activates Smad1/5/8 but not Smad2/3 in MSC cultures. Primary MSC mouse cells were starved from serum for 4 h and then 25 ng/ml of PDGF-AA was added to the cultures. Cells were harvested at different time points and were lysed to analyze the activation of Smad1/5/8 and Smad2/3 by western blot. Right panel: quantitation data. B. BMPRIA deficiency diminished Smad1/5/8 activation at the basal level or in response to PDGF-AA. Primary mouse MSC cells were infected with control virus or virus expressing Cre and selected for 5 days, to knock out BMPRIA. These cells were serum starved and treated with PDGF-AA for 2 hrs. Cells were harvested to analyze the activation of Smad1/5/8 by western blot. Right panel: quantitation data. C. BMPRI inhibitor LDN-193189 diminished Smad1/5/8 activation at the basal level or in response to PDGF-AA. Primary mouse MSC cells were serum starved for 4 hrs, pretreated with LDN-193189 for 1 hr and then treated with PDGF-AA for different periods of time. Cells were harvested to analyze the activation of Smad1/5/8 by western blot. Data are means ±s.e.m. (n = 3 for all panels). * p<0.05, when compared to empty vectors or untreated cells.
Figure 1 PDGF-AA activates BMP-Smad1/5/8 pathway via BMPRIA in MSC cells. A. PDGF-AA activates Smad1/5/8 but not Smad2/3 in MSC cultures. Primary MSC mouse cells were starved from serum for 4 h and then 25 ng/ml of PDGF-AA was added to the cultures. Cells were harvested at different time points and were lysed to analyze the activation of Smad1/5/8 and Smad2/3 by western blot. Right panel: quantitation data. B. BMPRIA deficiency diminished Smad1/5/8 activation at the basal level or in response to PDGF-AA. Primary mouse MSC cells were infected with control virus or virus expressing Cre and selected for 5 days, to knock out BMPRIA. These cells were serum starved and treated with PDGF-AA for 2 hrs. Cells were harvested to analyze the activation of Smad1/5/8 by western blot. Right panel: quantitation data. C. BMPRI inhibitor LDN-193189 diminished Smad1/5/8 activation at the basal level or in response to PDGF-AA. Primary mouse MSC cells were serum starved for 4 hrs, pretreated with LDN-193189 for 1 hr and then treated with PDGF-AA for different periods of time. Cells were harvested to analyze the activation of Smad1/5/8 by western blot. Data are means ±s.e.m. (n = 3 for all panels). * p<0.05, when compared to empty vectors or untreated cells.CC BY · PubMed Central
Figure 2 PDGF-AA promotes MSC osteogenic differentiation. A. PDGF-AA promotes ALP expression in MSC, which requires BMP-Smad1/5/8 signaling. Primary mouse MSC cells were cultured with or without PDGF-AA for 7 or 14 days. To test the effect of BMPRI activation, LDN-193189 was included in the culture medium. ALP was stained 7 or 14 days after culture. B. Quantitation data for ALP activities that were normalized to the total protein levels of each culture. C. PDGF-AA promotes bone mineralization in MSC, which requires BMP-Smad1/5/8 signaling. Primary mouse MSC cells were cultured in differentiation medium with or without PDGF-AA (changed every 3 days) for 28 days. To test the effect of BMPRI activation, LDN-193189 was included in the culture medium. Mineralization was stained with Von Kossa and Alizarin red method. D. PDGF-AA up-regulated the mRNA levels of Runx2, Atf4, and Osx via the BMP-Smad1/5/8 signaling, without affecting the mRNA levels of Sox9, C/EBPα, or PPARγ. Primary MSC cells were cultured with or without PDGF-AA for 7 days. To test the effect of BMPRI activation, LDN-193189 was included in the culture medium. Total RNA was isolated from the cells and realtime PCR was carried out to determine the mRNA levels of the six transcription factors. Data are means ±s.e.m. (n = 3 for all panels). * p<0.05, when compared to empty vectors or untreated cells. E. PDGF-AA up-regulated the protein levels of Runx2, Atf4, and Osx via the BMP-Smad1/5/8 signaling. The experiments were carried out as described in Fig. 2D and the protein levels of these proteins were determined by western blot.
Figure 2 PDGF-AA promotes MSC osteogenic differentiation. A. PDGF-AA promotes ALP expression in MSC, which requires BMP-Smad1/5/8 signaling. Primary mouse MSC cells were cultured with or without PDGF-AA for 7 or 14 days. To test the effect of BMPRI activation, LDN-193189 was included in the culture medium. ALP was stained 7 or 14 days after culture. B. Quantitation data for ALP activities that were normalized to the total protein levels of each culture. C. PDGF-AA promotes bone mineralization in MSC, which requires BMP-Smad1/5/8 signaling. Primary mouse MSC cells were cultured in differentiation medium with or without PDGF-AA (changed every 3 days) for 28 days. To test the effect of BMPRI activation, LDN-193189 was included in the culture medium. Mineralization was stained with Von Kossa and Alizarin red method. D. PDGF-AA up-regulated the mRNA levels of Runx2, Atf4, and Osx via the BMP-Smad1/5/8 signaling, without affecting the mRNA levels of Sox9, C/EBPα, or PPARγ. Primary MSC cells were cultured with or without PDGF-AA for 7 days. To test the effect of BMPRI activation, LDN-193189 was included in the culture medium. Total RNA was isolated from the cells and realtime PCR was carried out to determine the mRNA levels of the six transcription factors. Data are means ±s.e.m. (n = 3 for all panels). * p<0.05, when compared to empty vectors or untreated cells. E. PDGF-AA up-regulated the protein levels of Runx2, Atf4, and Osx via the BMP-Smad1/5/8 signaling. The experiments were carried out as described in Fig. 2D and the protein levels of these proteins were determined by western blot.CC BY · PubMed Central
Figure 3 PDGF-AA promotes MSC migration via BMP-Smad1/5/8 signaling. A. Transwell experiments and quantitation data. Migration of MSCs was evaluated using a transwell chamber equipped with an 8-µm-pore filter membrane. Cells were plated at 5×104 cells/well in serum-free media onto the upper compartment of the chamber and cultured in the absence or presence of PDGF-AA for 24 h. The filter membrane was removed, fixed with methanol, and stained with 0.1% crystal violet. Lower panel: the number of cells that had migrated to the lower surface of the filter membrane was counted in 5 random fields under a light scope (×200). B. PDGF-AA promotes expression of BMP-Smad1/5/8-controlled genes that regulate cell migration. Primary mouse MSC cells were cultured with or without PDGF-AA for 7 days. To test the effect of BMPRI activation, LDN-193189 was included in the culture medium. Total RNA was isolated from the cells and realtime-PCR was carried out to determine the mRNA levels of genes that are involved in regulating cell migration. Data are means±s.e.m. (n = 3). * p<0.05, **, P<0.01 when compared to empty vectors or untreated cells.
Figure 3 PDGF-AA promotes MSC migration via BMP-Smad1/5/8 signaling. A. Transwell experiments and quantitation data. Migration of MSCs was evaluated using a transwell chamber equipped with an 8-µm-pore filter membrane. Cells were plated at 5×104 cells/well in serum-free media onto the upper compartment of the chamber and cultured in the absence or presence of PDGF-AA for 24 h. The filter membrane was removed, fixed with methanol, and stained with 0.1% crystal violet. Lower panel: the number of cells that had migrated to the lower surface of the filter membrane was counted in 5 random fields under a light scope (×200). B. PDGF-AA promotes expression of BMP-Smad1/5/8-controlled genes that regulate cell migration. Primary mouse MSC cells were cultured with or without PDGF-AA for 7 days. To test the effect of BMPRI activation, LDN-193189 was included in the culture medium. Total RNA was isolated from the cells and realtime-PCR was carried out to determine the mRNA levels of genes that are involved in regulating cell migration. Data are means±s.e.m. (n = 3). * p<0.05, **, P<0.01 when compared to empty vectors or untreated cells.CC BY · PubMed Central
Figure 4 PDGFRα shows an inhibitory effect on Smad1/5/8 activation. A. PDGFRα knockdown enhanced Smad1/5/8 activation at the basal level but diminished PDGF-AA-induced Smad1/5/8 activation. Primary mouse MSC cells were transfected with control or siRNA against PDGFRα for 2 days. The cells were then treated with PDGF-AA for 2 hrs. Cells were harvested to analyze the activation of Smad1/5/8 by western blot. Right panel: quantitation data. B. PDGFRα knockdown enhanced Smad1/5/8 activation in response to BMP2. Primary mouse MSC cells were transfected with control or siRNA against PDGFRα for 2 days. The cells were then treated with 50 ng/ml of BMP2 for 0.5 or 1 hr. Cells were harvested to analyze the activation of Smad1/5/8 by western blot. Right panel: quantitation data. C. Inhibition of lysosome-mediated protein degradation diminished PDGF-AA-induced Smad1/5/8 activation. Primary mouse MSC cells were pretreated with chloroquine or NH4Cl for 6 h and then treated with PDGF-AA for 1 or 2 hrs. Cells were harvested to analyze the activation of Smad1/5/8 by western blot. Lower panel: quantitation data. Data are means ±s.e.m. (n = 3 for all panels). *, p<0.05, when compared to empty vectors or untreated cells.
Figure 4 PDGFRα shows an inhibitory effect on Smad1/5/8 activation. A. PDGFRα knockdown enhanced Smad1/5/8 activation at the basal level but diminished PDGF-AA-induced Smad1/5/8 activation. Primary mouse MSC cells were transfected with control or siRNA against PDGFRα for 2 days. The cells were then treated with PDGF-AA for 2 hrs. Cells were harvested to analyze the activation of Smad1/5/8 by western blot. Right panel: quantitation data. B. PDGFRα knockdown enhanced Smad1/5/8 activation in response to BMP2. Primary mouse MSC cells were transfected with control or siRNA against PDGFRα for 2 days. The cells were then treated with 50 ng/ml of BMP2 for 0.5 or 1 hr. Cells were harvested to analyze the activation of Smad1/5/8 by western blot. Right panel: quantitation data. C. Inhibition of lysosome-mediated protein degradation diminished PDGF-AA-induced Smad1/5/8 activation. Primary mouse MSC cells were pretreated with chloroquine or NH4Cl for 6 h and then treated with PDGF-AA for 1 or 2 hrs. Cells were harvested to analyze the activation of Smad1/5/8 by western blot. Lower panel: quantitation data. Data are means ±s.e.m. (n = 3 for all panels). *, p<0.05, when compared to empty vectors or untreated cells.CC BY · PubMed Central
Figure 5 PDGFRα interacts with BMPRIA. A. PDGFRα (His tagged) was co-expressed with BMPRIA(HA tagged) in 293T cells. The cells were treated with 25 ng/ml PDGF-AA for 0.5 or 2 h or untreated. Cell lysates were divided into two parts for analysis of PDGFRα and BMPRIA expression by western blot, or immunoprecipitation of PDGFRα to test whether BMPRIA was brought down with PDGFRα. B. PDGFRα (His tagged) was co-expressed with BMPRIA(HA tagged) in 293T cells. The cells were treated with 25 ng/ml PDGF-AA for 0.5 or 2 h or untreated. Cell lysates were divided into two parts for analysis of PDGFRα and BMPRIA expression by western blot, or immunoprecipitation of BMPRIA to test whether PDGFRα was brought down with BMPRIA. C. Co-immunoprecipitation of endogenous PDGFRα and BMPRIA. Primary MSC cells were lyzed and cleaned lysates were incubated with IgG, anti-BMPRIA antibodies, or anti-PDGFRα antibodies overnight at 4°C. The immunoprecipitated proteins and their interacting proteins were detected by western blot.
Figure 5 PDGFRα interacts with BMPRIA. A. PDGFRα (His tagged) was co-expressed with BMPRIA(HA tagged) in 293T cells. The cells were treated with 25 ng/ml PDGF-AA for 0.5 or 2 h or untreated. Cell lysates were divided into two parts for analysis of PDGFRα and BMPRIA expression by western blot, or immunoprecipitation of PDGFRα to test whether BMPRIA was brought down with PDGFRα. B. PDGFRα (His tagged) was co-expressed with BMPRIA(HA tagged) in 293T cells. The cells were treated with 25 ng/ml PDGF-AA for 0.5 or 2 h or untreated. Cell lysates were divided into two parts for analysis of PDGFRα and BMPRIA expression by western blot, or immunoprecipitation of BMPRIA to test whether PDGFRα was brought down with BMPRIA. C. Co-immunoprecipitation of endogenous PDGFRα and BMPRIA. Primary MSC cells were lyzed and cleaned lysates were incubated with IgG, anti-BMPRIA antibodies, or anti-PDGFRα antibodies overnight at 4°C. The immunoprecipitated proteins and their interacting proteins were detected by western blot.CC BY · PubMed Central
Figure 6 PDGFRα interferes with BMPRI-BMPRII interaction. A. PDGFRα (His tagged) was co-expressed with BMPRIA (HA tagged) and BMPRII (Flag tagged) in 293T cells. The cells were treated with 25 ng/ml PDGF-AA for 0.5 or 2 h or untreated. Cell lysates were divided into two parts for analysis of BMPRIA and BMPRII expression by western blot, or immunoprecipitation of BMPRIA to test whether the level of BMPRII brought down with BMPRIA was affected by expression of PDGFRα. Right panel: quantitation data. *, p<0.05, when compared to empty vectors transfected cells. B. PDGFRα (His tagged) was co-expressed with BMPRIA (HA tagged) and BMPRII (Flag tagged) in 293T cells. The cells were treated with 25 ng/ml PDGF-AA for 0.5 or 2 h or untreated. Cell lysates were divided into two parts for analysis of BMPRIA and BMPRII expression by western blot, or immunoprecipitation of BMPRII to test whether the level of BMPRIA brought down with BMPRII was affected by expression of PDGFRα. Right panel: quantitation data. *, p<0.05, when compared to empty vectors transfected cells.
Figure 6 PDGFRα interferes with BMPRI-BMPRII interaction. A. PDGFRα (His tagged) was co-expressed with BMPRIA (HA tagged) and BMPRII (Flag tagged) in 293T cells. The cells were treated with 25 ng/ml PDGF-AA for 0.5 or 2 h or untreated. Cell lysates were divided into two parts for analysis of BMPRIA and BMPRII expression by western blot, or immunoprecipitation of BMPRIA to test whether the level of BMPRII brought down with BMPRIA was affected by expression of PDGFRα. Right panel: quantitation data. *, p<0.05, when compared to empty vectors transfected cells. B. PDGFRα (His tagged) was co-expressed with BMPRIA (HA tagged) and BMPRII (Flag tagged) in 293T cells. The cells were treated with 25 ng/ml PDGF-AA for 0.5 or 2 h or untreated. Cell lysates were divided into two parts for analysis of BMPRIA and BMPRII expression by western blot, or immunoprecipitation of BMPRII to test whether the level of BMPRIA brought down with BMPRII was affected by expression of PDGFRα. Right panel: quantitation data. *, p<0.05, when compared to empty vectors transfected cells.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Research works printed but not linked: 2

  1. J Caverzasio, 2013, Predominant role of PDGF receptor transactivation in Wnt3a-induced osteoblastic cell proliferation, J Bone Miner Res, 28, 260, 10.1002/jbmr.1748 · DOI
  2. AI Caplan, 2011, PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs, J Orthop Res, 29, 1795, 10.1002/jor.21462 · DOI · Paper page

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Li, A., Xia, X., Yeh, J., Kua, H., Liu, H., Mishina, Y., Hao, A., & Li, B.
Affiliations
  • Shandong University (CN)
  • Shanghai Jiao Tong University (CN)
  • University of Michigan (US)
Corresponding author
  • Hao, Aijun
  • Li, Baojie
ORCID
Venue
PLoS ONE
Publisher
Public Library of Science (PLoS)
Published
2014-12-03
Volume
9
Issue
12
Pages
e113785
ISSN
1932-6203 (ISSN-L)
DOI
10.1371/journal.pone.0113785
PMC
PMC4254917
OpenAlex
W2011964589
Cited by
100
References
57
Citations by year
2026: 4 · 2025: 2 · 2024: 6 · 2023: 14 · 2022: 9 · 2021: 6 · 2020: 16 · 2019: 16 · 2018: 8 · 2017: 9 · 2016: 6 · 2015: 4
FWCI
2.60
Type
journal article
Language
en
Open access
Licence
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
National Natural Science Foundation of China (81121001, 31071229, 81130039)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords
PDGF-AA, platelet-derived growth factor, mesenchymal stem cells, osteogenic differentiation, cell migration, PDGFRA, BMP signaling, Smad1/5/8, BMPR-IA, BMPR2, TWIST1, ATF4, feedback regulation, skeletal development, fracture healing
MeSH terms
Animals, Cell Differentiation, Cell Movement, Cells, Cultured, Mice, Inbred C57BL, Osteogenesis, Platelet-Derived Growth Factor, Protein Binding, Blotting, Western, Signal Transduction, Down-Regulation, Mice, Knockout, Receptor, Platelet-Derived Growth Factor alpha, RNA Interference, Smad Proteins, Smad1 Protein, Smad5 Protein, Smad8 Protein, Bone Morphogenetic Protein Receptors, Type I, Bone Morphogenetic Protein 2, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review